Table 2.
Baseline chemokine levels in seropositive and seronegative RA patients. Values are presented as mean with standard deviation. P values were determined by Wilcoxon ranked sum test
| IgM RF+ (n = 16) | IgM RF- (n = 13) | p value | |
| CXCL10 (pg/ml) | 510.2 ± 465.2 | 400.4 ± 525.3 | 0.16 |
| CXCL13 (pg/ml) | 371.6 ± 649.0 | 40.3 ± 55.6 | 0.02* |
| CCL20 (pg/ml) | 9.7 ± 10.3 | 23.8 ± 30.5 | 0.09 |
| Anti-CCP+ (n = 15) | Anti-CCP- (n = 14) | p value | |
| CXCL10 (pg/ml) | 557.3 ± 458.0 | 357.8 ± 512.9 | 0.02* |
| CXCL13 (pg/ml) | 396.6 ± 663.8 | 37.2 ± 54.4 | 0.005* |
| CCL20 (pg/ml) | 9.6 ± 9.9 | 22.9 ± 29.7 | 0.12 |
IgG immunoglobulin G, RF rheumatoid factor, CXCL10 C-X-C motif chemokine 10, CXCL13 C-X-C motif chemokine 13, CCL20 C-C motif chemokine 20, anti-CCP anti-cyclic citrullinated peptide
*p < 0.05